Black Diamond Therapeutics (BDTX) EV/EBITDA US GAAP (year values)

FY2021 FY2022 FY2023 FY2024 FY2025   LTM ?
EV/EBITDA ? -0.09 1.03 1.23 -0.53 1.22   -0.53
Changes by years, y/y, % -99% -1 223% +20% -143% -331%    

Black Diamond Therapeutics. EV/EBITDA

Black Diamond Therapeutics. EV/EBITDA, changes, %

Black Diamond Therapeutics (BDTX) EV/EBITDA US GAAP (quarter values)

FY2025Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2026Q1   LTM ?
EV/EBITDA ? 11.7 2.38 5.43 0.98 -0.53   -0.53
Changes by years, y/y, % +998% +108% -382% -273% -105%    
Changes by quarters, q/q, % -2 158% -80% +128% -82% -154%    

Black Diamond Therapeutics. EV/EBITDA

Black Diamond Therapeutics. EV/EBITDA, changes, y/y, %

Black Diamond Therapeutics. EV/EBITDA, changes, q/q, %